PHOENIXBIOTECHNOLOGY.COM: Keyword Density Checker

Total words: 851 | 2-word phrases: 223 | 3-word phrases: 238 | 4-word phrases: 242

PAGE INFO

Title	Try to keep the title under 60 characters (26 characters) Phoenix Biotechnology, Inc
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	therapy focus	4	1.79%
2	biotechnology inc	4	1.79%
3	neurodegenerative diseases	3	1.35%
4	diseases product	3	1.35%
5	phoenix biotechnology	3	1.35%
6	infectivity of	2	0.90%
7	products in	2	0.90%
8	diseases cancer	2	0.90%
9	cancer neurodegenerative	2	0.90%
10	development of	2	0.90%
11	porcine viruses	2	0.90%
12	product development	2	0.90%
13	pbi05204 pbi01207	2	0.90%
14	in development	2	0.90%
15	and pbi05204	2	0.90%
16	pbi01207 pbi04711	2	0.90%
17	focus viral	2	0.90%
18	safety resources	2	0.90%
19	safe and	2	0.90%
20	and effective	2	0.90%

#	Keyword	Frequency	Density
1	phoenix biotechnology inc	3	1.26%
2	management team boards	2	0.84%
3	diseases product development	2	0.84%
4	therapy focus viral	2	0.84%
5	focus therapy focus	2	0.84%
6	safe and effective	2	0.84%
7	board therapy focus	2	0.84%
8	advisory board therapy	2	0.84%
9	products in development	2	0.84%
10	neurodegenerative diseases product	2	0.84%
11	therapy focus therapy	2	0.84%
12	company management team	2	0.84%
13	us company management	2	0.84%
14	about us company	2	0.84%
15	home about us	2	0.84%
16	pbi05204 pbi01207 pbi04711	2	0.84%
17	pbi01207 pbi04711 safety	2	0.84%
18	pbi04711 safety resources	2	0.84%
19	team boards of	2	0.84%
20	inhibit infectivity of	1	0.42%
21	infectivity of three	1	0.42%
22	of three important	1	0.42%
23	to inhibit infectivity	1	0.42%
24	pbi05204 to inhibit	1	0.42%
25	porcine viruses these	1	0.42%
26	and pbi05204 to	1	0.42%
27	skip to content	1	0.42%
28	viruses these data	1	0.42%
29	these data showing	1	0.42%
30	data showing nontoxic	1	0.42%

#	Keyword	Frequency	Density
1	pbi01207 pbi04711 safety resources	2	0.83%
2	about us company management	2	0.83%
3	board therapy focus therapy	2	0.83%
4	advisory board therapy focus	2	0.83%
5	pbi05204 pbi01207 pbi04711 safety	2	0.83%
6	management team boards of	2	0.83%
7	company management team boards	2	0.83%
8	focus therapy focus viral	2	0.83%
9	us company management team	2	0.83%
10	home about us company	2	0.83%
11	neurodegenerative diseases product development	2	0.83%
12	therapy focus therapy focus	2	0.83%
13	research demonstrates the potency	1	0.41%
14	the research demonstrates the	1	0.41%
15	demonstrates the potency of	1	0.41%
16	oleandrin and pbi05204 to	1	0.41%
17	and pbi05204 to inhibit	1	0.41%
18	2024 the research demonstrates	1	0.41%
19	pbi05204 to inhibit infectivity	1	0.41%
20	june 2024 the research	1	0.41%
21	management june 2024 the	1	0.41%
22	skip to content phoenix	1	0.41%
23	to inhibit infectivity of	1	0.41%
24	infectivity of three important	1	0.41%
25	porcine viruses these data	1	0.41%
26	viruses these data showing	1	0.41%
27	these data showing nontoxic	1	0.41%
28	data showing nontoxic concentrations	1	0.41%
29	showing nontoxic concentrations of	1	0.41%
30	oleandrin as a single	1	0.41%
31	as a single common	1	0.41%
32	a single common agent	1	0.41%
33	inhibit infectivity of three	1	0.41%
34	pbi05204 against viruses of	1	0.41%
35	to commercial pig health	1	0.41%
36	mediated diseases neuroprotection and	1	0.41%
37	further efforts toward development	1	0.41%
38	efforts toward development of	1	0.41%
39	toward development of therapies	1	0.41%
40	development of therapies in	1	0.41%

#	URL	Whois	Check